Corbus Pharmaceuticals (CRBP)
NASDAQ:CRBP
Holding CRBP?
Track your performance easily

Corbus Pharmaceuticals (CRBP) Financial Statements

2,187 Followers

Corbus Pharmaceuticals Financial Overview

Corbus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-5.82; its P/E ratio is -8.48; Corbus Pharmaceuticals is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-0.94. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -10.25M$ -7.05M$ -10.71M$ -9.27M$ -7.96M
EBITDA$ -9.97M$ -6.71M$ -10.56M$ -8.92M-
Net Income Common Stockholders$ -10.06M$ -6.90M$ -8.02M$ -10.04M$ -8.78M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 147.03M$ 120.10M$ 20.91M$ 28.73M$ 36.76M
Total Assets$ 151.98M$ 125.74M$ 28.27M$ 36.28M$ 43.72M
Total Debt$ 14.80M$ 17.29M$ 20.88M$ 22.86M$ 23.72M
Net Debt$ -132.23M$ -102.82M$ -21.77K$ -5.88M$ -13.04M
Total Liabilities$ 26.44M$ 28.78M$ 35.18M$ 35.97M$ 34.20M
Stockholders Equity$ 125.52M$ 96.97M$ -6.90M$ 311.02K$ 9.52M
Cash Flow-
Free Cash Flow$ -8.94M$ -7.97M$ -6.01M$ -7.18M-
Operating Cash Flow$ -8.94M$ -7.97M$ -6.01M$ -7.18M-
Investing Cash Flow$ -16.44M$ -98.24M$ 10.39M$ 10.90M-
Financing Cash Flow$ 34.96M$ 106.58M$ -1.90M$ -820.50K-
Currency in USD

Corbus Pharmaceuticals Earnings and Revenue History

Corbus Pharmaceuticals Debt to Assets

Corbus Pharmaceuticals Cash Flow

Corbus Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis